Back
Intensity Therapeutics, Inc. 10K Form
Sell
44
INTS
Intensity Therapeutics, Inc.
Last Price:
$0.50
Seasonality Move:
-9.18%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive INTS News And Ratings
See the #1 stock for the next 7 days that we like better than INTS
INTS Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-2.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.15 |
| Price / Book: | 4.24 |
Profitability
| EPS (TTM): | -0.63460 |
|---|---|
| Net Income (TTM): | $-11.7M |
| Gross Margin: | $-25K |
| Return on Equity: | -380.13% |
| Return on Assets: | -216.62% |
Intensity Therapeutics, Inc. Earnings Forecast
Key Intensity Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 6 years have been positive in 2 years.
Intensity Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | INTS |
| Website: | intensitytherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 3.6 |
| Quick Ratio: | 3.11 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
INTS Technical Analysis vs Fundamental Analysis
Sell
44
Intensity Therapeutics, Inc. (INTS)
is a Sell
Is Intensity Therapeutics, Inc. a Buy or a Sell?
-
Intensity Therapeutics, Inc. stock is rated a SellThe current Intensity Therapeutics, Inc. [INTS] share price is $0.51. The Score for INTS is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.